Document is current
Any future updates will be listed below
-
Authors
Park, Lily J
Polley, Hannah
Poole, Meredith
Brar, Karanbir
McKechnie, Tyler
Nenshi, Rahima
Borges, Flavia K
Ofori, Sandra
Marcucci, Maura
Conen, David
Lee, Yung
Anvari, Mehran
Eskicioglu, Cagla
Hong, Dennis
Devereaux, PJ
- License Information
-
More Information
Article History
Received: 1 December 2025
Revised: 2 February 2026
Accepted: 13 March 2026
First Online: 8 April 2026
Declarations
:
: Blinded Conflict of Interest Disclosure Statement: Author 7 received an Investigator Initiated Grant from Roche Diagnostics. Author 10 has received research grants from the Canadian Institutes of Health Research and advisory board fees from Abbott. Author 15 has received grants from Abbott Diagnostics, AOP Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, CloudDx, Coviden, Octapharma, Philips Healthcare, Roche Diagnostics, Siemens, and Stryker. Author 14 has also participated in advisory board meetings for GlaxoSmithKline, Boehringer Ingelheim, Bayer and Quidel Canada andhas been a speaker with Bayer Inc. and Novartis Pharma Canada. None of the above stated are directly related to the present work.
